Skip to main content

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

GMED holding history

Globus Medical Inc in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GMED overviewAll 13F holders of GMEDFull Q2 2026 holdings

Shares (Q2 2026)
13,523
Value
$1.07M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GMED by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,523$1.07M<0.1%−40.0%ReducedHolders
Q1 202613,527$1.17M<0.1%+3,123+30.0%AddedHolders
Q4 202510,404$908.4K<0.1%−2,182−17.3%ReducedHolders
Q3 202512,586$720.8K<0.1%−117−0.9%ReducedHolders
Q2 202512,703$749.7K<0.1%−448−3.4%ReducedHolders
Q1 202513,151$962.7K<0.1%+259+2.0%AddedHolders
Q4 202412,892$1.07M<0.1%+767+6.3%AddedHolders
Q3 202412,125$867.4K<0.1%+54+0.4%AddedHolders
Q2 202412,071$826.7K<0.1%−5,029−29.4%ReducedHolders
Q1 202417,100$917.2K<0.1%+38+0.2%AddedHolders
Q4 202317,062$909.2K<0.1%−579−3.3%ReducedHolders
Q3 202317,641$875.9K<0.1%+8,008+83.1%AddedHolders
Q2 20239,633$573.5K<0.1%−1,016−9.5%ReducedHolders
Q1 202310,649$603.2K<0.1%−35−0.3%ReducedHolders
Q4 202210,684$793.5K<0.1%+1,028+10.6%AddedHolders
Q3 20229,656$575.0K<0.1%−429−4.3%ReducedHolders
Q2 202210,085$566.0K<0.1%+1,108+12.3%AddedHolders
Q1 20228,977$662.0K<0.1%−258−2.8%ReducedHolders
Q4 20219,235$667.0K<0.1%+194+2.1%AddedHolders
Q3 20219,041$693.0K<0.1%−233−2.5%ReducedHolders
Q2 20219,274$719.0K<0.1%+1,143+14.1%AddedHolders
Q1 20218,131$501.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.